Transcatheter Interventions Online 2023 - On Demand
Published: 17 March 2023
1h 2sPart 2 | Session 7 Session 2.3: Left Main & Bifurcations
1h 1m 6sPart 2 | Session 8 Session 2.4: Live Cases and Discussion
1m 38sPart 2 | Session 9 Day Close
2m 49sPart 3 | Session 1 Day Welcome: Debates & Controversies
59m 8sPart 3 | Session 2 Session 3.1: Keynote & Debate
1h 1m 40sPart 3 | Session 3 Session 3.2: Live Cases and Discussion
54m 54sPart 3 | Session 5 Session 3.3: Debates
3m 4sPart 3 | Session 6 Day Close
3m 4sPart 1 | Session 1 Day Welcome: Structural Heart Disease Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, Lars Søndergaard, Didier Tchétché, Holger Thiele
58m 10sPart 1 | Session 2 Session 1.1: Atrioventricular Valve Replacement Beyond TEER? Azeem Latib, Kendra J Grubb, Lars Søndergaard, Didier Tchétché, Holger Thiele
1h 5m 20sPart 1 | Session 3 Session 1.2: Live Cases and Discussions Azeem Latib, Kendra J Grubb, Nicolas M Van Mieghem, Lars Søndergaard, Didier Tchétché, Helge Möllmann, Philipp Lurz
44m 44sPart 1 | Session 4 Symposium: Contemporary Techniques for TAVI in Complex Patients – Supported by an unrestricted educational grant by Medtronic Didier Tchétché, Kendra J Grubb, Ignacio J Amat-Santos, Darren Mylotte
30m 15sPart 1 | Session 5 Breakout: Large Hole Vascular Access and Closure: Techniques and Technologies – Supported by Vivasure Medical Nicolas M Van Mieghem
1h 8sPart 1 | Session 6 Session 1.3: Key Issues in TAVI Roxana Mehran, David Hildick-Smith, Lars Søndergaard, Giuseppe Tarantini
1h 2m 15sPart 1 | Session 7 Session 1.4: Live Cases and Discussions Roxana Mehran, David Hildick-Smith, Lars Søndergaard, Giuseppe Tarantini
1m 21sPart 1 | Session 8 Day Close Nicolas M Van Mieghem
55m 32sPart 2 | Session 1 Breakout: Jailed Pressure Guidewire: Can OptoWire III Turn a Nightmare into a New Standard in Bifurcation PCI? – Supported by OpSens Medical Jacek Legutko, Joost Daemen, Tomas Kovarnik
2m 52sPart 2 | Session 2 Day Welcome: Complex PCI Nicolas M Van Mieghem, David Hildick-Smith, Ajay J Kirtane, Azeem Latib, Margaret B McEntegart
1h 3mPart 2 | Session 3 Session 2.1: Balloon Revolution David Hildick-Smith, Ajay J Kirtane, Azeem Latib, Margaret B McEntegart, Nicolas M Van Mieghem
Welcome to the on-demand sessions of Transcatheter Interventions Online 2023, broadcast live on 15-17 March 2023. If you missed the live broadcast, here you can access all sessions in full.
TIO 2023 brought together a leading international faculty to create a rich, interactive experience to support the global interventional cardiology community stay abreast of the latest developments in transcatheter treatment strategies. Combining expert opinion and discussion, presentations and live cases from centres of excellence from both sides of the Atlantic, TIO 2023 again delivered best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
The live version of Transcatheter Interventions Online 2023 was CME-accredited. This on-demand version is not.
A CME-accredited version of each session of TIO 2023 will soon be available on Radcliffe Medical Education.
Key Learning Objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Day One: Structural Heart Disease
Day Two: Complex PCI
Day Three: Debates and Controversies
Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.
A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment.
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research interests are in clinical trial…
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care.
He is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.
Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal…
Margaret B McEntegart
Consultant in Interventional Cardiology
Dr McEntegart is a Consultant Interventional Cardiologist at Golden Jubilee National Hospital and Honorary Associate Clinical Professor of the University of Glasgow, and clinical lead for the complex PCI and CTO programmes.
Nicolas M Van Mieghem
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Joost is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Joost is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.
In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.